Putnam Biorevolution Etf Profile
| SYNB Etf | USD 28.75 0.09 0.31% |
PerformanceVery Weak
| Odds Of DistressLow
|
Putnam Biorevolution is trading at 28.75 as of the 22nd of March 2025, a 0.31 percent decrease since the beginning of the trading day. The etf's open price was 28.84. Putnam Biorevolution has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
The fund invests mainly in common stocks of companies worldwide of any size with a focus on biology revolution companies. Putnam Biorevolution is traded on NYSEARCA Exchange in the United States. More on Putnam Biorevolution ETF
Moving together with Putnam Etf
Moving against Putnam Etf
Putnam Etf Highlights
| Thematic Ideas | (View all Themes) |
| Business Concentration | Theme ETFs, Strategy ETFs, Health, Putnam (View all Sectors) |
| Issuer | Putnam Investments |
| Inception Date | 2022-09-29 |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 5.07 Million |
| Asset Type | Equity |
| Category | Strategy |
| Focus | Theme |
| Market Concentration | Blended Development |
| Region | Global |
| Administrator | State Street Bank and Trust Company |
| Advisor | Putnam Investment Management, LLC |
| Custodian | State Street Bank and Trust Company |
| Distributor | Foreside Fund Services, LLC |
| Portfolio Manager | William Rives |
| Transfer Agent | State Street Bank and Trust Company |
| Fiscal Year End | 30-Apr |
| Exchange | NYSE Arca, Inc. |
| Number of Constituents | 38.0 |
| Market Maker | RBC Capital Markets |
| Total Expense | 0.7 |
| Management Fee | 0.7 |
| 200 Day M A | 31.0977 |
| Country Name | USA |
| 50 Day M A | 29.7427 |
| Code | SYNB |
| Updated At | 21st of March 2025 |
| Returns Y T D | (2.46) |
| Name | Putnam Biorevolution ETF |
| Currency Name | US Dollar |
| Currency Code | USD |
| Open Figi | BBG019VG8625 |
| Type | ETF |
| 1y Volatility | 13.11 |
Putnam Biorevolution ETF [SYNB] is traded in USA and was established 2022-09-29. The fund is listed under Health category and is part of Putnam family. The entity is thematically classified as Theme ETFs. Putnam Biorevolution ETF at this time have in assets. , while the total return for the last year was -5.9%.
Check Putnam Biorevolution Probability Of Bankruptcy
Geographic Allocation (%)
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Putnam Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Putnam Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Putnam Biorevolution ETF Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Putnam Biorevolution ETF Currency Exposure
Putnam Biorevolution ETF holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of Putnam Biorevolution will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in Putnam Biorevolution ETF.
Top Putnam Biorevolution ETF Etf Constituents
| VRTX | Vertex Pharmaceuticals | Stock | Health Care | |
| CTVA | Corteva | Stock | Materials | |
| AVTR | Avantor | Stock | Health Care | |
| NGVT | Ingevity Corp | Stock | Materials | |
| LEGN | Legend Biotech Corp | Stock | Health Care | |
| ZTS | Zoetis Inc | Stock | Health Care | |
| BMRN | Biomarin Pharmaceutical | Stock | Health Care | |
| ALNY | Alnylam Pharmaceuticals | Stock | Health Care |
Putnam Biorevolution ETF Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Putnam Biorevolution. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.02) | |||
| Treynor Ratio | (0.15) |
Putnam Biorevolution Against Markets
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Putnam Biorevolution ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
The market value of Putnam Biorevolution ETF is measured differently than its book value, which is the value of Putnam that is recorded on the company's balance sheet. Investors also form their own opinion of Putnam Biorevolution's value that differs from its market value or its book value, called intrinsic value, which is Putnam Biorevolution's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Putnam Biorevolution's market value can be influenced by many factors that don't directly affect Putnam Biorevolution's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Putnam Biorevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if Putnam Biorevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Putnam Biorevolution's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.